These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20166933)

  • 1. Recent advances in anti-survivin treatments for cancer.
    Kanwar RK; Cheung CH; Chang JY; Kanwar JR
    Curr Med Chem; 2010; 17(15):1509-15. PubMed ID: 20166933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cells survive with survivin.
    Yamamoto H; Ngan CY; Monden M
    Cancer Sci; 2008 Sep; 99(9):1709-14. PubMed ID: 18537980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting survivin in cancer therapy: fulfilled promises and open questions.
    Pennati M; Folini M; Zaffaroni N
    Carcinogenesis; 2007 Jun; 28(6):1133-9. PubMed ID: 17341657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid.
    Huang RC; Chang CC; Mold D
    Semin Oncol; 2006 Aug; 33(4):479-85. PubMed ID: 16890802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin, a cancer target with an emerging role in normal adult tissues.
    Fukuda S; Pelus LM
    Mol Cancer Ther; 2006 May; 5(5):1087-98. PubMed ID: 16731740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
    Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
    Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
    J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of survivin in mitosis].
    Wolanin K; Piwocka K
    Postepy Biochem; 2007; 53(1):10-8. PubMed ID: 17718383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Old Flame Never Dies: Survivin in Cancer and Cellular Senescence.
    Unruhe B; Schröder E; Wünsch D; Knauer SK
    Gerontology; 2016; 62(2):173-81. PubMed ID: 26159786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of survivin: the past, present and future.
    Cheung CH; Cheng L; Chang KY; Chen HH; Chang JY
    Front Biosci (Landmark Ed); 2011 Jan; 16(3):952-61. PubMed ID: 21196211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splice variants of survivin as potential targets in cancer.
    Sampath J; Pelus LM
    Curr Drug Discov Technol; 2007 Oct; 4(3):174-91. PubMed ID: 17986000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin, versatile modulation of cell division and apoptosis in cancer.
    Altieri DC
    Oncogene; 2003 Nov; 22(53):8581-9. PubMed ID: 14634620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
    Yang L; Cao Z; Yan H; Wood WC
    Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy by disabling crossroad signaling networks: the survivin paradigm.
    Altieri DC
    Mol Cancer Ther; 2006 Mar; 5(3):478-82. PubMed ID: 16546961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activity.
    Barrett RM; Osborne TP; Wheatley SP
    Cell Cycle; 2009 Jan; 8(2):278-83. PubMed ID: 19158485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.
    Yamamoto T; Manome Y; Nakamura M; Tanigawa N
    Eur J Cancer; 2002 Nov; 38(17):2316-24. PubMed ID: 12441269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin: a protein with dual roles in mitosis and apoptosis.
    Wheatley SP; McNeish IA
    Int Rev Cytol; 2005; 247():35-88. PubMed ID: 16344111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential.
    Lippert BM; Knauer SK; Fetz V; Mann W; Stauber RH
    Int J Cancer; 2007 Sep; 121(6):1169-74. PubMed ID: 17617794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
    Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.